Literature DB >> 228989

Development of specific inhibitors of angiotensin I converting enzyme (kininase II).

D W Cushman, H S Cheung, E F Sabo, B Rubin, M A Ondetti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228989

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


× No keyword cloud information.
  8 in total

1.  Involvement of Kallikrein-Kinin System on Cardiopulmonary Alterations and Inflammatory Response Induced by Purified Aah I Toxin from Scorpion Venom.

Authors:  Wafa Medjadba; Marie-France Martin-Eauclaire; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 2.  Drug discovery in renin-angiotensin system intervention: past and future.

Authors:  Bryan Williams
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-04-27

3.  How adverse drug reactions can play a role in innovative drug research.

Authors:  F Rikken; R Vos
Journal:  Pharm World Sci       Date:  1995-11-24

4.  Research in pediatric surgery.

Authors:  C J Stolar; R P Altman
Journal:  World J Surg       Date:  1985-04       Impact factor: 3.352

5.  Prorenin: What are its functions?

Authors:  Takaaki Senbonmatsu
Journal:  Hypertens Res       Date:  2022-10-07       Impact factor: 5.528

6.  Induction of ornithine decarboxylase by renin-free nerve growth factor.

Authors:  G Guroff; P Montgomery; N Tolson; M E Lewis; D End
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

Review 7.  [Captopril in congestive heart failure (author's transl)].

Authors:  G Liebau
Journal:  Klin Wochenschr       Date:  1982-02-01

8.  Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis.

Authors:  Christopher A Rushworth; Jodie L Guy; Anthony J Turner
Journal:  FEBS J       Date:  2008-12       Impact factor: 5.542

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.